AnaptysBio, Inc.ANABNASDAQ
LOADING
|||
Switch Symbol:
EPS Growth Accelerating
Trending higher, above historical average.
Left:
||||
Year-over-year earnings per share growth rate
Latest
140.30%
↑ 348% above average
Average (39q)
-56.48%
Historical baseline
Range
High:355.18%
Low:-1428.66%
CAGR
NaN%
Modest growth trend
| Period | Value |
|---|---|
| Q3 2025 | 140.30% |
| Q2 2025 | -4.69% |
| Q1 2025 | -66.23% |
| Q4 2024 | 32.46% |
| Q3 2024 | 33.33% |
| Q2 2024 | -4.27% |
| Q1 2024 | -4.46% |
| Q4 2023 | -11.35% |
| Q3 2023 | 6.00% |
| Q2 2023 | 13.29% |
| Q1 2023 | -86.02% |
| Q4 2022 | 29.55% |
| Q3 2022 | 0.00% |
| Q2 2022 | 10.20% |
| Q1 2022 | -24.58% |
| Q4 2021 | -391.67% |
| Q3 2021 | -1428.66% |
| Q2 2021 | 97.62% |
| Q1 2021 | -153.66% |
| Q4 2020 | 241.38% |
| Q3 2020 | -10.13% |
| Q2 2020 | -163.33% |
| Q1 2020 | 60.00% |
| Q4 2019 | 34.78% |
| Q3 2019 | -29.21% |
| Q2 2019 | -8.54% |
| Q1 2019 | -28.12% |
| Q4 2018 | 3.03% |
| Q3 2018 | -15.79% |
| Q2 2018 | 9.52% |
| Q1 2018 | -110.00% |
| Q4 2017 | 33.33% |
| Q3 2017 | -246.15% |
| Q2 2017 | 82.67% |
| Q1 2017 | -150.00% |
| Q4 2016 | -280.71% |
| Q3 2016 | -149.25% |
| Q2 2016 | 355.18% |
| Q1 2016 | 74.92% |
| Q4 2015 | -150.00% |